266 related articles for article (PubMed ID: 29047408)
1. The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial.
Inoue T; Takagi H; Owada Y; Watanabe Y; Yamaura T; Fukuhara M; Muto S; Okabe N; Matsumura Y; Hasegawa T; Osugi J; Hoshino M; Higuchi M; Shio Y; Yokouchi H; Kanazawa K; Ohbuchi K; Fukushima T; Munakata M; Suzuki H
Trials; 2017 Oct; 18(1):485. PubMed ID: 29047408
[TBL] [Abstract][Full Text] [Related]
2. Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02).
Ohnishi S; Watari H; Kanno M; Ohba Y; Takeuchi S; Miyaji T; Oyamada S; Nomura E; Kato H; Sugiyama T; Asaka M; Sakuragi N; Yamaguchi T; Uezono Y; Iwase S
J Gynecol Oncol; 2017 Sep; 28(5):e44. PubMed ID: 28657216
[TBL] [Abstract][Full Text] [Related]
3. Prospective, randomized, cross-over pilot study of the effects of Rikkunshito, a Japanese traditional herbal medicine, on anorexia and plasma-acylated ghrelin levels in lung cancer patients undergoing cisplatin-based chemotherapy.
Yoshiya T; Mimae T; Ito M; Sasada S; Tsutani Y; Satoh K; Masuda T; Miyata Y; Hattori N; Okada M
Invest New Drugs; 2020 Apr; 38(2):485-492. PubMed ID: 31428894
[TBL] [Abstract][Full Text] [Related]
4. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism.
Takeda H; Sadakane C; Hattori T; Katsurada T; Ohkawara T; Nagai K; Asaka M
Gastroenterology; 2008 Jun; 134(7):2004-13. PubMed ID: 18439428
[TBL] [Abstract][Full Text] [Related]
5. Antiemetic Effect of Rikkunshito, a Japanese Kampo Herbal Medicine, on Cisplatin-induced Nausea and Vomiting: A Nationwide Database Study in Japan.
Jo T; Shigemi D; Konishi T; Yamana H; Michihata N; Kumazawa R; Yokoyama A; Urushiyama H; Matsui H; Fushimi K; Nagase T; Yasunaga H
Intern Med; 2024 Apr; 63(7):919-927. PubMed ID: 37495535
[TBL] [Abstract][Full Text] [Related]
6. Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial.
Yang XB; Wu WY; Long SQ; Deng H; Pan ZQ; He WF; Zhou YS; Liao GY; Li QP; Xiao SJ; Cai JZ
Trials; 2015 Apr; 16():146. PubMed ID: 25873045
[TBL] [Abstract][Full Text] [Related]
7. Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.
Rowland KM; Loprinzi CL; Shaw EG; Maksymiuk AW; Kuross SA; Jung SH; Kugler JW; Tschetter LK; Ghosh C; Schaefer PL; Owen D; Washburn JH; Webb TA; Mailliard JA; Jett JR
J Clin Oncol; 1996 Jan; 14(1):135-41. PubMed ID: 8558188
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of Yukgunja-Tang for treating anorexia in patients with cancer: The protocol for a pilot, randomized, controlled trial.
Kang HJ; Jeong MK; Park SJ; Jun HJ; Yoo HS
Medicine (Baltimore); 2019 Oct; 98(40):e16950. PubMed ID: 31577697
[TBL] [Abstract][Full Text] [Related]
9. Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the Kampo medicine rikkunshito on the model.
Terawaki K; Kashiwase Y; Sawada Y; Hashimoto H; Yoshimura M; Ohbuchi K; Sudo Y; Suzuki M; Miyano K; Shiraishi S; Higami Y; Yanagihara K; Hattori T; Kase Y; Ueta Y; Uezono Y
PLoS One; 2017; 12(3):e0173113. PubMed ID: 28249026
[TBL] [Abstract][Full Text] [Related]
10. Rikkunshito as a ghrelin enhancer.
Takeda H; Muto S; Nakagawa K; Ohnishi S; Sadakane C; Saegusa Y; Nahata M; Hattori T; Asaka M
Methods Enzymol; 2012; 514():333-51. PubMed ID: 22975063
[TBL] [Abstract][Full Text] [Related]
11. Effects of rikkunshito, a kampo medicine, on quality of life after proximal gastrectomy.
Gunji S; Ueda S; Yoshida M; Kanai M; Terajima H; Takabayashi A
J Surg Res; 2013 Dec; 185(2):575-80. PubMed ID: 23856127
[TBL] [Abstract][Full Text] [Related]
12. Modified Liujunzi Decoction () Alleviates Chemotherapy-Induced Anorexia in Advanced Non-Small Cell Lung Cancer: A Propensity Score Matched Case-Control Study.
Sun LL; Lai HZ; Chen ZZ; Zhu XS; Lin LZ
Chin J Integr Med; 2020 Apr; 26(4):256-262. PubMed ID: 31970675
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of Jianpishengsui for chemotherapy-related fatigue in patients with non-small cell lung cancer: study protocol for a randomized placebo-controlled clinical trial.
Xiao Z; Hu L; Lin J; Lu L; Huang X; Zhu X; Teo C; Lin L
Trials; 2020 Jan; 21(1):94. PubMed ID: 31948475
[TBL] [Abstract][Full Text] [Related]
14. Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study.
Hiura Y; Takiguchi S; Yamamoto K; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Miyata H; Fujiwara Y; Mori M; Kangawa K; Doki Y
Cancer; 2012 Oct; 118(19):4785-94. PubMed ID: 22282373
[TBL] [Abstract][Full Text] [Related]
15. Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial.
Paz-Ares L; de Marinis F; Dediu M; Thomas M; Pujol JL; Bidoli P; Molinier O; Sahoo TP; Laack E; Reck M; Corral J; Melemed S; John W; Chouaki N; Zimmermann AH; Visseren-Grul C; Gridelli C
Lancet Oncol; 2012 Mar; 13(3):247-55. PubMed ID: 22341744
[TBL] [Abstract][Full Text] [Related]
16. Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction.
Yakabi K; Kurosawa S; Tamai M; Yuzurihara M; Nahata M; Ohno S; Ro S; Kato S; Aoyama T; Sakurada T; Takabayashi H; Hattori T
Regul Pept; 2010 Apr; 161(1-3):97-105. PubMed ID: 20171995
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis.
Matsuda C; Munemoto Y; Mishima H; Nagata N; Oshiro M; Kataoka M; Sakamoto J; Aoyama T; Morita S; Kono T
Cancer Chemother Pharmacol; 2015 Jul; 76(1):97-103. PubMed ID: 25983022
[TBL] [Abstract][Full Text] [Related]
18. Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia.
Yakabi K; Sadakane C; Noguchi M; Ohno S; Ro S; Chinen K; Aoyama T; Sakurada T; Takabayashi H; Hattori T
Endocrinology; 2010 Aug; 151(8):3773-82. PubMed ID: 20534732
[TBL] [Abstract][Full Text] [Related]
19. The novel preventive effect of a Japanese ethical Kampo extract formulation TJ-90 (Seihaito) against cisplatin-induced nephrotoxicity.
Ikeda Y; Funamoto M; Kishi S; Imanishi M; Aihara KI; Kashiwada Y; Tsuchiya K
Phytomedicine; 2022 Aug; 103():154213. PubMed ID: 35671634
[TBL] [Abstract][Full Text] [Related]
20. The gene expression of the hypothalamic feeding-regulating peptides in cisplatin-induced anorexic rats.
Yoshimura M; Matsuura T; Ohkubo J; Ohno M; Maruyama T; Ishikura T; Hashimoto H; Kakuma T; Yoshimatsu H; Terawaki K; Uezono Y; Ueta Y
Peptides; 2013 Aug; 46():13-9. PubMed ID: 23684922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
